SCHEMBL7723507

SCHEMBL7723507

C=CCOc1ccccc1C(=N)N

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIG1 P18858 1/20 0.58
KDM4E B2RXH2 3/20 0.50
TSHR P16473 3/20 0.49
HPGD P15428 2/20 0.49
HSD17B10 Q99714 2/20 0.49
MAPK1 P28482 1/20 0.49
CYP3A4 P08684 1/20 0.43
ADRB2 P07550 2/20 0.43
ADRB1 P08588 2/20 0.43
ADRB3 P13945 1/20 0.43
GAA P10253 1/20 0.42
ALDH1A1 P00352 3/20 0.41
SLC22A1 O15245 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
HTR1A P08908 1/20 0.41
CYP2D6 P10635 1/20 0.41
HTR2A P28223 1/20 0.41
SLC6A4 P31645 1/20 0.41
ADRA1A P35348 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7722654 0.98 LIG1 (0.56) LIG1KDM4ETSHRHPGDHSD17B10
SCHEMBL17439057 0.85 LIG1 (0.47) LIG1KDM4ETSHRHPGDHSD17B10
SCHEMBL3798396 0.83 KDM4E (0.71) LIG1KDM4ETSHRHPGDHSD17B10
SCHEMBL3219478 0.80 LIG1 (0.68) LIG1KDM4ETSHRHPGDHSD17B10
SCHEMBL30997962 0.80 LIG1 (0.55) LIG1KDM4ETSHRHPGDHSD17B10
SCHEMBL9696302 0.79 LIG1 (0.71) LIG1KDM4ETSHRHPGDHSD17B10
SCHEMBL9857038 0.78 LMNA (0.51) KDM4ECYP3A4ALDH1A1LMNAHTT
SCHEMBL40310 0.77 LIG1 (0.69) LIG1KDM4ETSHRHPGDHSD17B10
SCHEMBL9474674 0.77 LIG1 (0.59) LIG1KDM4ETSHRHPGDHSD17B10
SCHEMBL29519569 0.77 LIG1 (0.69) LIG1KDM4ETSHRHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391885-B1 CONTROLLING APOPTOSIS IN AUTOIMMUNE DISEASE CELL PATHWAYS, INC. 2002-05-21 US disclosed
US-6060477-A Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives CELL PATHWAYS, INC. (US) 2000-05-09 US disclosed
EP-0351058-B1 PYRIMIDOPYRIMIDINE DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1993-06-02 EP disclosed
US-5162316-A Pyrimido[4,5-d]pyrimidine derivatives for use as bronchodilators SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1992-11-10 US disclosed
EP-0351058-A1 Pyrimidopyrimidine derivatives SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1990-01-17 EP disclosed